Yixi Zhang, MD
Internal Medicine · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 4
- Since medical school
- 11 years
- Harvard Medical School, 2015
Offices
4 locations · Peninsula Hospitalist Associates Inc · Galen Inpatient Physicians PC · San Francisco Unified Physicians Group, Inc · Permanente Medical Group Inc
Looking this up.
Hospitals listed: Chinese Hospital · Marinhealth Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Zhang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A166644 · Current
Licensed to practise in California · since 2019 · expires 2027-11-30 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Chinese HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
See every measure and the patient survey for Chinese Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 104 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.64 to 1.61) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.6 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 66 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 569 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 766 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 749 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.34 (0.76 to 5.93) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.13 (0.4 to 3.85) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.57 to 4.02) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.72 (0 to 18.54) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.04 (0.78 to 9.3) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.59) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 543 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.392 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 111 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 33 · 78 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.3 · 64 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 148 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.1) · 478 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 39 cases | No different | Jan 2024 – Dec 2024 |
What patients said (160 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$36,426
Medicare paid this office $36,426 for 240 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 160 | $23,471 | $143 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 64 | $7,231 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,904 | $94 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,362 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,251 | $63 |
Who their Medicare patients are
240 Original Medicare patients in 2024. Average age 79 · Women 55% · Also on Medicaid 26% · Health risk score 2.11. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · Atrial fibrillation 43% · Chronic kidney disease 42% · Heart failure 39% · Depression 38% · Diabetes 29% · Stroke 29% · COPD 28% · Dementia 25% · Cancer 18%.
The office billed $167,024, Medicare allowed $47,864 and paid $36,426; for 301 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 240 | 301 | 79 | 2.11 | $167,024 | $36,426 |
| 2023 | 50 | 141 | 75 | 2.54 | $23,277 | $12,538 |
| 2022 | 187 | 1,791 | 76 | 2.39 | $364,746 | $187,894 |
| 2021 | 196 | 1,634 | 76 | 2.86 | $400,615 | $179,148 |
| 2020 | 190 | 812 | 74 | 3.27 | $144,528 | $64,844 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $4,800 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,859 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,425 | $62 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,454 | $91 |
2022: 15 services
| Long return visit (40+ min) | 116 | $66,980 | $151 |
| Return visit (30+ min) | 116 | $39,206 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $14,190 | $87 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 90 | $12,898 | $143 |
| Advance care planning, first 30 minutes | 99 | $8,574 | $73 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $7,626 | $166 |
| New patient visit (60+ min) | 40 | $6,479 | $162 |
| Transitional care management services for problem of high complexity | 18 | $5,126 | $244 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | 49 | $4,328 | $41 |
| Hospital discharge day management, more than 30 minutes | 37 | $4,064 | $90 |
| New patient visit (45+ min) | 20 | $1,863 | $93 |
| Influenza vaccine, quadrivalent derived from cell cultures | 61 | $1,828 | $30 |
| Administration of influenza virus vaccine | 61 | $1,793 | $29 |
| Annual depression screening, 5 to 15 minutes | 67 | $1,388 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 54 | $743 | $13 |
2021: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $65,225 | $88 |
| Long return visit (40+ min) | 70 | $26,337 | $159 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $26,084 | $170 |
| Return visit (30+ min) | 61 | $12,928 | $110 |
| Hospital discharge day management, more than 30 minutes | 91 | $11,014 | $92 |
| New patient visit (60+ min) | 39 | $7,390 | $189 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 43 | $6,305 | $147 |
| Transitional care management services for problem of at least moderate complexity | 31 | $6,001 | $182 |
| Transitional care management services for problem of high complexity | 11 | $2,904 | $242 |
| New patient visit (45+ min) | 21 | $2,809 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,967 | $61 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 43 | $883 | $21 |
| Administration of influenza virus vaccine | 37 | $710 | $19 |
| Annual depression screening, 5 to 15 minutes | 13 | $276 | $21 |
2020: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 111 | $25,434 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $9,017 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 60 | $7,781 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,692 | $175 |
| Hospital discharge day management, 30 minutes or less | 49 | $3,160 | $63 |
| Hospital discharge day management, more than 30 minutes | 25 | $2,526 | $94 |
| Hospital observation care on day of discharge | 14 | $876 | $63 |
| Influenza vaccine, quadrivalent derived from cell cultures | 17 | $471 | $28 |
| Administration of influenza virus vaccine | 17 | $322 | $19 |
Medicaid work
$3,787 in 2024
Medicaid paid $3,787 for 52 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 28 | $2,252 |
| 1ST HOSP IP/OBS HIGH 75 | 24 | $1,535 |
| 2024 | 52 | 2 | 16 | $3,787 |
| 2023 | 65 | 3 | 15 | $1,747 |
| 2022 | 230 | 3 | 21 | $4,593 |
| 2020 | 133 | 1 | 17 | $4,037 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 25 | $676 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 25 | $551 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 15 | $519 |
2022
| Long return visit (40+ min) | 120 | $3,392 |
| Return visit (30+ min) | 75 | $723 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 35 | $479 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 133 | $4,037 |
Drugs they prescribed that Part D paid
$14,569
Pharmacies billed $14,569 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
112 generic and fewer than 11 brand-name prescriptions · $14,569 in drug cost · 13 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Brimonidine | 14 | $2,429 | $173 |
| Vascepa | 15 | $1,993 | $133 |
| Memantine | 12 | $1,385 | $115 |
| Pilocarpine | 12 | $1,129 | $94 |
| Alendronate | 12 | $158 | $13 |
Year by year
| 2024 | 166 | 37 | None | None | $14,569 |
| 2023 | 1,512 | 173 | None | None | $225,098 |
| 2022 | 3,933 | 181 | 1% (46) | 20% | $535,547 |
| 2021 | 853 | 125 | None | None | $84,484 |
| 2020 | 152 | 46 | None | None | $7,551 |
| 2019 | 45 | 22 | None | 33% | $3,916 |
| 2018 | 24 | 13 | 0% (0) | None | $1,655 |
| 2017 | 155 | 61 | None | 14% | $2,956 |
| 2016 | 30 | None | None | None | $2,935 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Vascepa | 98 | $41,777 | $426 |
| Jardiance | 19 | $24,832 | $1,307 |
| Janumet | 21 | $16,210 | $772 |
| Livalo | 12 | $6,219 | $518 |
| Dexlansoprazole Dr | 13 | $3,030 | $233 |
| Diclofenac | 29 | $2,712 | $94 |
| Atorvastatin | 126 | $2,049 | $16 |
| Rosuvastatin | 73 | $1,582 | $22 |
| Celecoxib | 40 | $1,558 | $39 |
| Omega-3 Acid Ethyl Esters | 16 | $1,046 | $65 |
| Levothyroxine | 51 | $982 | $19 |
| Olmesartan Medoxomil | 22 | $971 | $44 |
| Raloxifene | 16 | $849 | $53 |
| Alendronate | 54 | $804 | $15 |
| Amlodipine Besylate | 44 | $751 | $17 |
| Nifedipine Er | 14 | $718 | $51 |
| Losartan | 50 | $703 | $14 |
| Montelukast | 51 | $643 | $13 |
| Lisinopril | 26 | $465 | $18 |
| Metformin | 41 | $448 | $11 |
| Allopurinol | 31 | $332 | $11 |
| Tamsulosin | 13 | $323 | $25 |
| Ezetimibe | 11 | $315 | $29 |
| Levocetirizine Dihydrochloride | 13 | $298 | $23 |
| Fenofibrate | 15 | $296 | $20 |
| Valsartan | 13 | $293 | $23 |
| Metoprolol | 23 | $265 | $12 |
| Carvedilol | 11 | $204 | $19 |
| Pantoprazole | 13 | $193 | $15 |
| Lactulose | 11 | $181 | $16 |
| Gabapentin | 11 | $165 | $15 |
| Trazodone | 13 | $151 | $12 |
| Atenolol | 14 | $133 | $9 |
| Simvastatin | 17 | $115 | $7 |
| Zolpidem | 12 | $104 | $9 |
| Folic Acid | 14 | $40 | $3 |
2022: 83 drugs
| Vascepa | 177 | $73,566 | $416 |
| Janumet | 65 | $41,641 | $641 |
| Jardiance | 42 | $33,178 | $790 |
| Januvia | 34 | $30,311 | $891 |
| Prolia | 18 | $27,793 | $1,544 |
| Victoza 3-Pak | 20 | $22,907 | $1,145 |
| Creon | 30 | $22,041 | $735 |
| Trulicity | 22 | $21,076 | $958 |
| Farxiga | 29 | $18,799 | $648 |
| Myrbetriq | 23 | $11,612 | $505 |
| Tradjenta | 13 | $10,350 | $796 |
| Dexlansoprazole Dr | 24 | $10,184 | $424 |
| Dexilant | 20 | $7,987 | $399 |
| Linzess | 13 | $7,637 | $587 |
| Celecoxib | 97 | $6,424 | $66 |
| Advair Diskus | 14 | $5,891 | $421 |
| Lidocaine | 36 | $5,851 | $163 |
| Diclofenac | 95 | $5,383 | $57 |
| Rosuvastatin | 78 | $4,779 | $61 |
| Incruse Ellipta | 12 | $4,595 | $383 |
| Fenofibrate | 46 | $4,036 | $88 |
| Raloxifene | 29 | $3,741 | $129 |
| Nifedipine Er | 46 | $3,223 | $70 |
| Atorvastatin | 268 | $2,544 | $9 |
| Olmesartan Medoxomil | 36 | $2,311 | $64 |
| Megestrol Acetate | 29 | $2,142 | $74 |
| Pregabalin | 32 | $1,661 | $52 |
| Pantoprazole | 38 | $1,562 | $41 |
| Olmesartan-Hydrochlorothiazide | 21 | $1,473 | $70 |
| Omega-3 Acid Ethyl Esters | 23 | $1,467 | $64 |
| Levothyroxine | 80 | $1,315 | $16 |
| Montelukast | 81 | $1,290 | $16 |
| Amlodipine Besylate | 103 | $1,102 | $11 |
| Albuterol Sulfate Hfa | 24 | $1,088 | $45 |
| Ketoconazole | 26 | $926 | $36 |
| Memantine | 12 | $926 | $77 |
| Ezetimibe | 36 | $883 | $25 |
| Losartan | 117 | $811 | $7 |
| Alendronate | 80 | $809 | $10 |
| Lactulose | 43 | $731 | $17 |
| Valsartan | 12 | $646 | $54 |
| Metformin | 118 | $632 | $5 |
| Clopidogrel | 27 | $621 | $23 |
| Bumetanide | 26 | $609 | $23 |
| Hydralazine | 38 | $543 | $14 |
| Allopurinol | 46 | $524 | $11 |
| Tamsulosin | 50 | $518 | $10 |
| Finasteride | 33 | $494 | $15 |
| Triamcinolone Acetonide | 34 | $485 | $14 |
| Hydrocortisone | 14 | $457 | $33 |
| Azithromycin | 69 | $437 | $6 |
| Gabapentin | 60 | $404 | $7 |
| Levocetirizine Dihydrochloride | 41 | $377 | $9 |
| Zolpidem | 53 | $374 | $7 |
| Metoprolol | 38 | $364 | $10 |
| Ammonium Lactate | 17 | $361 | $21 |
| Donepezil | 23 | $343 | $15 |
| Omeprazole | 35 | $318 | $9 |
| Fenofibrate | 19 | $310 | $16 |
| Nebivolol | 12 | $310 | $26 |
| Glimepiride | 21 | $279 | $13 |
| Carvedilol | 17 | $273 | $16 |
| Lisinopril | 50 | $264 | $5 |
| Escitalopram | 26 | $249 | $10 |
| Fluticasone Propionate | 26 | $246 | $9 |
| Mirtazapine | 11 | $228 | $21 |
| Nitroglycerin | 12 | $221 | $18 |
| Trazodone | 23 | $210 | $9 |
| Paxlovid (Eua) | 20 | $195 | $10 |
| Potassium Chloride | 18 | $193 | $11 |
| Metoclopramide | 22 | $185 | $8 |
| Tramadol | 43 | $175 | $4 |
| Glipizide Er | 16 | $160 | $10 |
| Nitrofurantoin Mono-Macro | 11 | $155 | $14 |
| Isosorbide Mononitrate Er | 16 | $149 | $9 |
| Simvastatin | 39 | $127 | $3 |
| Sulfamethoxazole-Trimethoprim | 14 | $107 | $8 |
| Clonidine | 20 | $100 | $5 |
| Metoprolol | 14 | $97 | $7 |
| Amoxicillin | 19 | $73 | $4 |
| Quetiapine | 11 | $66 | $6 |
| Sertraline | 14 | $53 | $4 |
| Prednisone | 18 | $36 | $2 |
2021: 22 drugs
| Januvia | 11 | $9,788 | $890 |
| Diclofenac | 41 | $2,574 | $63 |
| Lidocaine | 15 | $1,786 | $119 |
| Basaglar Kwikpen U-100 | 11 | $1,523 | $138 |
| Nifedipine Er | 17 | $1,421 | $84 |
| Megestrol Acetate | 13 | $782 | $60 |
| Rosuvastatin | 11 | $727 | $66 |
| Ketoconazole | 14 | $700 | $50 |
| Atorvastatin | 53 | $558 | $11 |
| Pantoprazole | 11 | $522 | $47 |
| Bumetanide | 11 | $406 | $37 |
| Levothyroxine | 31 | $364 | $12 |
| Amlodipine Besylate | 28 | $239 | $9 |
| Quetiapine | 19 | $210 | $11 |
| Metformin | 33 | $192 | $6 |
| Metoprolol | 16 | $171 | $11 |
| Carvedilol | 13 | $135 | $10 |
| Allopurinol | 12 | $126 | $10 |
| Levofloxacin | 11 | $100 | $9 |
| Losartan | 13 | $97 | $7 |
| Alendronate | 14 | $89 | $6 |
| Lisinopril | 18 | $48 | $3 |
2020: 1 drug
| Atorvastatin | 11 | $70 | $6 |
2017: 3 drugs
| Atorvastatin | 27 | $201 | $7 |
| Furosemide | 11 | $78 | $7 |
| Lisinopril | 12 | $52 | $4 |
Professional record
- NPI
- 1457709800
- Licence
- CA A166644California A166644: Current · expires 2027-11-30
- Trained
- Harvard Medical School, 2015 · 11 years ago
- Group
- Peninsula Hospitalist Associates Inc · Galen Inpatient Physicians PC · San Francisco Unified Physicians Group, Inc · Permanente Medical Group Inc
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Hospitalist (208M00000X)
- Mailing address
- 8679 Hayloft Pl, Riverside, CA, 92508
- NPI first listed
- 2016-05-26
- NPI last updated
- 2023-04-01
- NPI record certified
- 2023-04-01
This is when the NPI record was last certified, not a medical board exam.